Compliance Rate
Compliance Rate
25.0%
Compliant submissions
2
Incompliant submissions
6
Total trials
8
My Organizations' Clinical Trials
Showing 525 of 1120 entries
View as:
Phase: N/A
Priority: Normal
Start: 10/31/05
End: 08/31/10
Due: 08/31/11
Phase: N/A
Priority: Normal
Start: 04/08/22
End: 09/02/22
Due: 09/02/23
Phase: N/A
Priority: Normal
Start: 12/31/15
End: 02/28/23
Due: 02/28/24
Phase: N/A
Priority: Normal
Start: 05/31/09
End: 02/28/11
Due: 02/28/12
Phase: N/A
Priority: Normal
Start: 04/30/14
End: 07/31/16
Due: 07/31/17
Phase: N/A
Priority: Normal
Start: 08/31/98
End: 12/31/14
Due: 12/31/15
Phase: N/A
Priority: Normal
Start: 12/11/19
End: 01/31/20
Due: 01/31/21
Phase: N/A
Priority: Normal
Start: 03/01/25
End: 09/30/26
Due: 09/30/27
Phase: N/A
Priority: Normal
Start: 11/30/11
End: 07/10/18
Due: 07/10/19
Phase: N/A
Priority: Normal
Start: 06/30/08
End: 10/31/08
Due: 10/31/09
Phase: N/A
Priority: Normal
Start: 06/30/07
End: 04/30/10
Due: 04/30/11
Phase: N/A
Priority: Normal
Start: 03/31/13
End: 09/30/13
Due: 09/30/14
Phase: N/A
Priority: Normal
Start: 01/28/16
End: 10/11/21
Due: 10/11/22
Phase: N/A
Priority: Normal
Start: 03/31/06
End: 06/30/09
Due: 06/30/10
Phase: N/A
Priority: Normal
Start: 08/30/19
End: 12/31/21
Due: 12/31/22
Phase: N/A
Priority: Normal
Start: 12/15/16
End: 05/18/17
Due: 05/18/18
Phase: N/A
Priority: Normal
Start: 03/31/09
End: 03/31/13
Due: 03/31/14
Does Liposomal Bupivacaine Provide Improved Pain Management for ORIF of Midshaft Clavicle Fractures?
Phase: N/A
Priority: Normal
Start: 08/23/17
End: 01/01/18
Due: 01/01/19
Phase: N/A
Priority: Normal
Start: 08/31/09
End: 04/30/10
Due: 04/30/11
Phase: N/A
Priority: Normal
Start: 10/01/16
End: 10/31/20
Due: 10/31/21
Phase: N/A
Priority: Normal
Start: 03/07/23
End: 04/01/25
Due: 04/01/26
Phase: N/A
Priority: Normal
Start: 06/02/25
End: 03/31/27
Due: 03/31/28
Phase: N/A
Priority: Normal
Start: 01/01/26
End: 12/01/30
Due: 12/01/31
Phase: N/A
Priority: Normal
Start: 01/31/17
End: 01/31/20
Due: 01/31/21
Phase: N/A
Priority: Normal
Start: 03/31/14
End: 06/28/17
Due: 06/28/18